We are live on
!
Find out more
CP
Castleview Partners Portfolio holdings
AUM
$228M
1-Year Est. Return
19.85%
This Fund
S&P 500
This Quarter
Est. Return
+6.43%
1 Year Est. Return
+19.85%
3 Year Est. Return
+54.5%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$173M
AUM Growth
-$2.52M
(-1.4%)
Cap. Flow
-$11.6M
Cap. Flow
% of AUM
-6.69%
Top 10 Holdings %
Top 10 Hldgs %
29.84%
Holding
957
New
42
Increased
209
Reduced
176
Closed
412
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.05M |
| 2 |
ProShares UltraPro QQQ
TQQQ
|
+$1.1M |
| 3 |
Regan Floating Rate MBS ETF
MBSF
|
+$1.09M |
| 4 |
CLOB
VanEck AA-BB CLO ETF
CLOB
|
+$965K |
| 5 |
Sprott Physical Silver Trust
PSLV
|
+$635K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alpha Architect 1-3 Month Box ETF
BOXX
|
+$7.39M |
| 2 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$1.77M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$1.28M |
| 4 |
Sprott Uranium Miners ETF
URNM
|
+$1.27M |
| 5 |
XVOL
Acruence Active Hedge US Equity ETF
XVOL
|
+$1.08M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 10.22% |
| 2 | Healthcare | 7.65% |
| 3 | Consumer Discretionary | 7.54% |
| 4 | Financials | 6.99% |
| 5 | Consumer Staples | 3.28% |
Similar funds
MWM
PCA
ATWA
BF
CWA
BWA
GC
KW
Castleview Partners's Q3 2024 Portfolio in Review
As of Q3 2024, Castleview Partners held 957 positions worth $173M, down 1.4% from $176M the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Castleview Partners withdrew a net $11.6M in Q3 2024, closing 412 positions and reducing 176 holdings. Its most notable exit was Invesco QQQ Trust, an estimated $1.28M position sold in full.
By sector, the portfolio is most concentrated in Technology at 10% of assets, up from 9.2% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Castleview Partners opened a new position in VanEck AA-BB CLO ETF worth $966K.
- Castleview Partners's largest Q3 2024 buy was VanEck AA-BB CLO ETF: 19,255 shares worth $966K.
- Castleview Partners added most to Bristol-Myers Squibb in Q3 2024, an estimated $2.05M increase.
- Castleview Partners's biggest Q3 2024 reduction was Alpha Architect 1-3 Month Box ETF, cutting an estimated $7.39M.
- Castleview Partners fully exited Invesco QQQ Trust in Q3 2024, selling an estimated $1.28M.
- Castleview Partners's ten largest holdings make up 30% of its $173M portfolio in Q3 2024.
- Castleview Partners opened 42 new positions and closed 412 in Q3 2024.
- Castleview Partners's portfolio value fell 1.4% quarter-over-quarter to $173M.
Based on Castleview Partners's 13F filing for Q3 2024, filed 9 Oct 2024.